Publication Date:
2014-03-15
Description:
〈br /〉〈span class="detail_caption"〉Notes: 〈/span〉Hyman, Steven E -- New York, N.Y. -- Science. 2014 Mar 14;343(6176):1177. doi: 10.1126/science.1252603.〈br /〉〈span class="detail_caption"〉Author address: 〈/span〉Steven E. Hyman is director of the Stanley Center for Psychiatric Research at the Broad Institute of Harvard and the Massachusetts Institute of Technology in Cambridge, MA, and a professor in the Department of Stem Cell and Regenerative Biology at Harvard University, Cambridge, MA.〈br /〉〈span class="detail_caption"〉Record origin:〈/span〉 〈a href="http://www.ncbi.nlm.nih.gov/pubmed/24626901" target="_blank"〉PubMed〈/a〉
Keywords:
Alzheimer Disease/drug therapy
;
Antipsychotic Agents/adverse effects/*therapeutic use
;
Arthritis, Rheumatoid/drug therapy
;
Diabetes Mellitus, Type 2/drug therapy
;
*Drug Discovery
;
Drug Industry/trends
;
Drug Prescriptions
;
Humans
;
International Cooperation
;
Lupus Erythematosus, Systemic/drug therapy
;
National Institutes of Health (U.S.)
;
Schizophrenia/*drug therapy/genetics
;
United States
Print ISSN:
0036-8075
Electronic ISSN:
1095-9203
Topics:
Biology
,
Chemistry and Pharmacology
,
Computer Science
,
Medicine
,
Natural Sciences in General
,
Physics
Permalink
